• Actinium Pharmaceuticals appointed Matt David chief financial officer to lead financial operations, capital markets and investor relations.
• David most recently served as CorMedix's executive vice president and chief business officer, having joined as chief financial officer in 2020.
• His background includes more than two decades across biopharmaceutical leadership, healthcare investment banking and equity research.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610150730PR_NEWS_USPR_____NY72959) on October 15, 2026, and is solely responsible for the information contained therein.